nach oben

Reactions Weekly

Erschienen in:

01.10.2019 | Case report

Trimebutine

Pruritic morbilliform skin eruption: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

A 61-year-old woman developed pruritic morbilliform skin eruption following treatment with trimebutine. She had presented with similar skin lesions after receiving medication containing trimebutine, two years before the current visit to clinic. She underwent oral provocation test. After a few hours, she developed similar generalised skin eruptions, confirming the diagnosis [route, dosage, indication, duration of treatment to reaction onset and outcome not stated]. …

Park GY, et al. A Case of Trimebutine-Induced Morbilliform Skin Eruption. World Allergy Organization Journal 18: 129, No. 2, Jan 2019. Available from: URL: http://doi.org/10.1186/s40413-016-0096-1 [abstract] - South Korea

Titel: Trimebutine
Pruritic morbilliform skin eruption: case report
Publikationsdatum: 01.10.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-69067-9

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Trimebutine

Pruritic morbilliform skin eruption: case report

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Denosumab

Levodopa

Diclofenac/ibuprofen

Paclitaxel

Aspirin/clopidogrel

Multiple drugs